257 related articles for article (PubMed ID: 16351509)
1. Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women.
Nhan S; Anderson KE; Nagamani M; Grady JJ; Lu LJ
Nutr Cancer; 2005; 53(1):73-81. PubMed ID: 16351509
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones.
Lu LJ; Cree M; Josyula S; Nagamani M; Grady JJ; Anderson KE
Cancer Res; 2000 Mar; 60(5):1299-305. PubMed ID: 10728690
[TBL] [Abstract][Full Text] [Related]
3. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention.
Lu LJ; Anderson KE; Grady JJ; Kohen F; Nagamani M
Cancer Res; 2000 Aug; 60(15):4112-21. PubMed ID: 10945618
[TBL] [Abstract][Full Text] [Related]
4. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans.
Wiseman H; O'Reilly JD; Adlercreutz H; Mallet AI; Bowey EA; Rowland IR; Sanders TA
Am J Clin Nutr; 2000 Aug; 72(2):395-400. PubMed ID: 10919933
[TBL] [Abstract][Full Text] [Related]
5. Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure.
Lu LJ; Lin SN; Grady JJ; Nagamani M; Anderson KE
Nutr Cancer; 1996; 26(3):289-302. PubMed ID: 8910911
[TBL] [Abstract][Full Text] [Related]
6. Equol producer status, salivary estradiol profile and urinary excretion of isoflavones in Irish Caucasian women, following ingestion of soymilk.
Hall MC; O'Brien B; McCormack T
Steroids; 2007 Jan; 72(1):64-70. PubMed ID: 17157887
[TBL] [Abstract][Full Text] [Related]
7. Effects of an isoflavone-free soy diet on ovarian hormones in premenopausal women.
Lu LJ; Anderson KE; Grady JJ; Nagamani M
J Clin Endocrinol Metab; 2001 Jul; 86(7):3045-52. PubMed ID: 11443166
[TBL] [Abstract][Full Text] [Related]
8. Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects.
Lu LJ; Grady JJ; Marshall MV; Ramanujam VM; Anderson KE
Nutr Cancer; 1995; 24(3):311-23. PubMed ID: 8610050
[TBL] [Abstract][Full Text] [Related]
9. Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake.
Atkinson C; Skor HE; Fitzgibbons ED; Scholes D; Chen C; Wähälä K; Schwartz SM; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):253-60. PubMed ID: 11895874
[TBL] [Abstract][Full Text] [Related]
10. Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans.
Lu LJ; Anderson KE
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1500S-1504S. PubMed ID: 9848524
[TBL] [Abstract][Full Text] [Related]
11. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake.
Arai Y; Uehara M; Sato Y; Kimira M; Eboshida A; Adlercreutz H; Watanabe S
J Epidemiol; 2000 Mar; 10(2):127-35. PubMed ID: 10778038
[TBL] [Abstract][Full Text] [Related]
12. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
[TBL] [Abstract][Full Text] [Related]
13. Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women.
Lampe JW; Skor HE; Li S; Wähälä K; Howald WN; Chen C
J Nutr; 2001 Mar; 131(3):740-4. PubMed ID: 11238753
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of isoflavones after ingestion of soy beverages in healthy adults.
Kano M; Takayanagi T; Harada K; Sawada S; Ishikawa F
J Nutr; 2006 Sep; 136(9):2291-6. PubMed ID: 16920843
[TBL] [Abstract][Full Text] [Related]
15. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women.
Setchell KD; Faughnan MS; Avades T; Zimmer-Nechemias L; Brown NM; Wolfe BE; Brashear WT; Desai P; Oldfield MF; Botting NP; Cassidy A
Am J Clin Nutr; 2003 Feb; 77(2):411-9. PubMed ID: 12540402
[TBL] [Abstract][Full Text] [Related]
16. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas.
Irvine CH; Shand N; Fitzpatrick MG; Alexander SL
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1462S-1465S. PubMed ID: 9848517
[TBL] [Abstract][Full Text] [Related]
17. Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study.
Nayeem F; Chen NW; Nagamani M; Anderson KE; Lu LW
Nutr Res; 2019 Aug; 68():70-81. PubMed ID: 31421395
[TBL] [Abstract][Full Text] [Related]
18. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
19. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity.
Zhang Y; Wang GJ; Song TT; Murphy PA; Hendrich S
J Nutr; 1999 May; 129(5):957-62. PubMed ID: 10222386
[TBL] [Abstract][Full Text] [Related]
20. Urinary isoflavonoid excretion and soy consumption in three generations of Japanese women in Hawaii.
Maskarinec G; Yamakawa R; Hebshi S; Franke AA
Eur J Clin Nutr; 2007 Feb; 61(2):255-61. PubMed ID: 16929241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
